Photocure ASA (0IMT.L) LSE
Currency In NOK
- General
- Statistics
- Historical Data
- Profile
- Financials
Photocure ASA
Sector
Healthcare
Industry
Biotechnology
Employees
99
First IPO Date
January 14, 2011
Key Executives
| Name | Title | Pay | Year Born |
| Daniel Schneider | President & Chief Executive Officer | 11.32M | N/A |
| Anja Gossens-von der Heidt | Head of Global Human Resources | 3.05M | N/A |
| Erik Dahl | Chief Financial Officer | 4.41M | 1957 |
| Anders Neijber | Chief Medical Officer of Global Medical Affairs, Clinical Development and R&D | 4.71M | N/A |
| Jane Healy | Vice President & General Manager of Europe | 4.89M | N/A |
| Priyam Shah | ????Vice President of Investor Relations | 0 | N/A |
| Tolv Hillestad | Group Controller | 0 | N/A |
Description
Photocure ASA operates as a specialized pharmaceutical company, managing the entire lifecycle of pharmaceutical products from initial research and development through to their manufacturing, distribution, marketing, and commercialization. Its operations span a wide geographical area, encompassing the Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European nations, and the United States. Among its primary offerings is Hexvix/Cysview, a product utilized for the detection and ongoing management of bladder cancer. Furthermore, the company is advancing Cevira, an investigational treatment aimed at addressing human papilloma virus infections and precancerous lesions found on the cervix. Photocure distributes its products to pharmaceutical wholesalers, pharmacies, and hospitals, leveraging a network of license partners. Established in 1993, the company is headquartered in Oslo, Norway.
